The Pathogenic A2V Mutant Exhibits Distinct Aggregation Kinetics, Metal Site Structure, and Metal Exchange of the Cu2+–Aβ Complex
Authors:
- Arun K. SomavarapuASArun K. Somavarapu
- Fei ShenFSFei Shen
- Kaare TeilumKTKaare Teilum
- Jingdong ZhangJZJingdong Zhang
- Susanne MossinSMSusanne Mossin
- Peter W. ThulstrupPeter W. Thulstrup
- Morten J. BjerrumMBMorten J. Bjerrum
- Manish K. TiwariMTManish K. Tiwari
- Daniel SzunyoghDSDaniel Szunyogh
- Kasper P. KeppKKKasper P. Kepp
- Lars HemmingsenLHLars Hemmingsen
- 5 September 2017
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 23 (55) , 13591-13595
Abstract
A prominent current hypothesis is that impaired metal ion homeostasis may contribute to Alzheimer's disease (AD). We elucidate the interaction of Cu2+ with wild‐type (WT) Aβ1–40 and the genetic variants A2T and A2V which display increasing pathogenicity as A2T2+ significantly extends the lag phase in aggregation kinetics, in particular for the pathogenic A2V variant. Additionally, a rapid, initial, low intensity ThT response is observed, possibly reflecting formation of Cu2+ induced amorphous aggregates, as supported by atomic force microscopy (AFM) and circular dichroism (CD) spectroscopy, again most notably for the A2V variant. Electron paramagnetic resonance (EPR) spectroscopy gives pKa values for transition between two Cu2+ coordination geometries (component I and II) of 7.4 (A2T), 7.9 (WT), and 8.4 (A2V), that is, component I is stabilized at physiological pH in the order A2T1H NMR relaxation exhibits the same trend for the non‐coordinating aromatic residues (A2T2+exchange for the A2V variant than for WT and A2T. We therefore hypothesize that component I of the Cu–Aβ complex is related to pathogenicity, accounting for both the pathogenic nature of the A2V variant and the protective nature of the A2T variant.Keywords
Funding Information
- Teknologi og Produktion, Det Frie Forskningsr&x00E5;d (DFF - 4005-00082)
- Lundbeck Foundation (R141-2013-13028)
- Carlsbergfondet (2012-01-0797)
This publication has 44 references indexed in Scilit:
- Copper prevents amyloid-β1–42 from forming amyloid fibrils under near-physiological conditions in vitroScientific Reports, 2013
- Amyloid-Beta (Aβ) D7H Mutation Increases Oligomeric Aβ42 and Alters Properties of Aβ-Zinc/Copper AssembliesPLOS ONE, 2012
- Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-β PeptidesJournal of Biological Chemistry, 2011
- Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA ReceptorsThe Journal of Neuroscience, 2011
- Alzheimer's Aβ Peptides with Disease-Associated N-Terminal Modifications: Influence of Isomerisation, Truncation and Mutation on Cu2+ CoordinationPLOS ONE, 2010
- Structure–neurotoxicity relationships of amyloid β-protein oligomersProceedings of the National Academy of Sciences, 2009
- A Recessive Mutation in the APP Gene with Dominant-Negative Effect on AmyloidogenesisScience, 2009
- Therapeutics for Alzheimer's Disease Based on the Metal HypothesisNeurotherapeutics, 2008
- A Century of Alzheimer's DiseaseScience, 2006